UNSPSC 51162043: Ipratropium bromide/fenoterol hydrobromide

Ipratropium bromide/fenoterol hydrobromide is a fixed combination of an anticholinergic agent and beta2-adrenergic agonist in patients with Asthma and Chronic Obstructive Pulmonary Disease.

UNSPSC 51162043 Ipratropium bromide/fenoterol hydrobromide is a Commodity code that nominally covers a specific pharmaceutical combination product, but the recent state and local opportunities block shows no procurement activity aligned with this code. The single substantive opportunity appearing in the dataset—Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems—targets different pharmaceutical products entirely and does not address ipratropium bromide/fenoterol hydrobromide. The remaining records in the block are vendor networking events, county relocation notices, surveys, and trade shows unrelated to any specific pharmaceutical procurement. No recent solicitations for ipratropium bromide/fenoterol hydrobromide or comparable respiratory combination inhalers appear in the current state and local opportunities tracked.

The code shows no identifiable activity among state or local issuing bodies—counties, municipalities, school districts, or state agencies—that would support a business development pursuit decision. Without evidence of actual buying patterns, geographic concentration, issuing-body repeat participation, or representative solicitations under this Commodity code, no actionable market signal is present. Watch this code if respiratory pharmaceutical procurement becomes visible, but do not pursue based on current activity.